Moreover, previous studies have shown that, out of the three anti-striational antibodies, anti-titin and anti-Kv 1.4 can be used as biomarkers for myocarditis and/or myositis in patients with MG, especially for late-onset and thymoma-associated cases [33,35]. This evidence concerns the gene TTN and myositis disease.